Table 7. The serum miR-4651 and the clinic-pathological features of HCC cases with resection treatment.
| miR-4651 negative (n = 27) | miR-4651 positive (n = 84) | |||||
|---|---|---|---|---|---|---|
| Features | n | % | n | % | OR (95% CI) | P |
| Age (years) | ||||||
| ≤ 48 | 16 | 59.3 | 42 | 50.0 | Reference | |
| > 48 | 11 | 40.7 | 42 | 50.0 | 1.40 (0.58-3.39) | 0.46 |
| Gender | ||||||
| Female | 3 | 11.1 | 15 | 17.9 | Reference | |
| male | 24 | 88.9 | 69 | 82.1 | 0.61 (0.16-2.30) | 0.46 |
| Race | ||||||
| Han | 11 | 40.7 | 38 | 45.2 | Reference | |
| Zhuang | 16 | 59.3 | 46 | 54.8 | 0.85 (0.35-2.06) | 0.72 |
| Tumor size | ||||||
| ≤ 3 cm | 20 | 74.1 | 56 | 66.7 | Reference | |
| > 3 cm | 7 | 25.9 | 28 | 33.3 | 1.43 (0.54-3.78) | 0.48 |
| Edmondson differentiation grade | ||||||
| I-II | 15 | 55.6 | 35 | 41.7 | Reference | |
| III-IV | 12 | 44.4 | 49 | 58.3 | 1.67 (0.69-4.05) | 0.26 |
| Liver cirrhosis | ||||||
| No | 19 | 69.2 | 62 | 73.8 | Reference | |
| Yes | 8 | 30.8 | 22 | 26.2 | 0.80 (0.30-3.11) | 0.66 |
| AFP20 | ||||||
| Negative | 25 | 92.6 | 43 | 51.2 | Reference | |
| Positive | 2 | 7.4 | 41 | 48.8 | 11.72 (2.59-53.01) | 1.40×10−3 |
| AFP400 | ||||||
| Negative | 26 | 96.3 | 57 | 67.9 | Reference | |
| Positive | 1 | 3.7 | 27 | 32.1 | 11.97 (1.53-93.74) | 0.02 |
Abbreviations: HCC, hepatocellular carcinoma, AFB1, aflatoxin B1.